1. Home
  2. ORKA vs NRDS Comparison

ORKA vs NRDS Comparison

Compare ORKA & NRDS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ORKA
  • NRDS
  • Stock Information
  • Founded
  • ORKA 2004
  • NRDS 2009
  • Country
  • ORKA United States
  • NRDS United States
  • Employees
  • ORKA N/A
  • NRDS N/A
  • Industry
  • ORKA Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • NRDS EDP Services
  • Sector
  • ORKA Health Care
  • NRDS Technology
  • Exchange
  • ORKA Nasdaq
  • NRDS Nasdaq
  • Market Cap
  • ORKA 354.2M
  • NRDS 810.0M
  • IPO Year
  • ORKA N/A
  • NRDS 2021
  • Fundamental
  • Price
  • ORKA $14.21
  • NRDS $10.59
  • Analyst Decision
  • ORKA Strong Buy
  • NRDS Buy
  • Analyst Count
  • ORKA 8
  • NRDS 6
  • Target Price
  • ORKA $39.71
  • NRDS $15.17
  • AVG Volume (30 Days)
  • ORKA 360.1K
  • NRDS 398.7K
  • Earning Date
  • ORKA 08-15-2025
  • NRDS 07-30-2025
  • Dividend Yield
  • ORKA N/A
  • NRDS N/A
  • EPS Growth
  • ORKA N/A
  • NRDS N/A
  • EPS
  • ORKA N/A
  • NRDS 0.38
  • Revenue
  • ORKA N/A
  • NRDS $734,900,000.00
  • Revenue This Year
  • ORKA N/A
  • NRDS $18.07
  • Revenue Next Year
  • ORKA N/A
  • NRDS $8.22
  • P/E Ratio
  • ORKA N/A
  • NRDS $28.03
  • Revenue Growth
  • ORKA N/A
  • NRDS 24.20
  • 52 Week Low
  • ORKA $5.49
  • NRDS $7.55
  • 52 Week High
  • ORKA $52.32
  • NRDS $16.45
  • Technical
  • Relative Strength Index (RSI)
  • ORKA N/A
  • NRDS 42.52
  • Support Level
  • ORKA N/A
  • NRDS $11.07
  • Resistance Level
  • ORKA N/A
  • NRDS $11.49
  • Average True Range (ATR)
  • ORKA 0.00
  • NRDS 0.32
  • MACD
  • ORKA 0.00
  • NRDS -0.04
  • Stochastic Oscillator
  • ORKA 0.00
  • NRDS 13.19

About ORKA Oruka Therapeutics Inc. Common Stock

Oruka Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing novel monoclonal antibody therapeutics for psoriasis (PsO) and other inflammatory and immunology (I&I) indications. Its lead program, ORKA-001, is designed to target the p19 subunit of interleukin-23 (IL-23p19) for the treatment of PsO. The company's co-lead program, ORKA-002, is designed to target interleukin-17A and interleukin-17F (IL-17A/F) for the treatment of PsO, psoriatic arthritis (PsA), and other conditions. These programs each bind their respective targets at high affinity and incorporate half-life extension technology to increase exposure and decreasing dosing frequency.

About NRDS NerdWallet Inc.

Nerdwallet Inc is a company that provides consumer-driven advice about personal finance through its platform by connecting individuals and small and mid-sized businesses (SMBs) with providers of financial products. It gets revenue from fees paid by its financial services partners in the form of either revenue per action, revenue per click, revenue per lead and revenue per funded loan arrangements.

Share on Social Networks: